Steven Marx
5Patents
2h-index
6Co-inventors
40Inventor score
Filing activity: May 10, 2000 → Dec 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6489125B1 | Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor | Physics | 9 | Expired |
| US7662178B2 | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis | Human Necessities | 4 | Active |
| US7364586B2 | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis | Human Necessities | 1 | Expired |
| US10925976B2 | Smooth muscle specific inhibition for anti-restenotic therapy | Chemistry; Metallurgy | 0 | Active |
| US11474098B2 | Drug target for preventing pathologic calcium overload in cardiomyocytes and methods of screening for same | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.